<DOC>
	<DOCNO>NCT02676531</DOCNO>
	<brief_summary>This study evaluate effect Walking Meditation vascular function breast cancer patient receive Anthracyclines chemotherapy</brief_summary>
	<brief_title>Walking Meditation Exercise Breast Cancer Patients</brief_title>
	<detailed_description>Walking Meditation program base aerobic walk exercise combine Buddhist meditation . The subject perform walk listen sound `` Budd '' `` Dha '' squeeze rubber ball accord sound order practice mindfulness walk . In phase 1 ( week 1-6 ) , Walking Meditation conduct initial moderate intensity ( 41-50 % heart rate reserve ) 3 set , 10 minute per set rest 3 minute set In phase 2 ( week 7-12 ) , train intensity increase ultimate moderate intensity ( 51-60 % heart rate reserve ) 3 set , 15 minute per set rest 3 minute set . In phase train , frequency Walking Meditation training three time week .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>1 . The inclusion criterion include stage 12 Breast cancer patient operation without Hormone Receptor Positive HER2 Positive . 2 . All participant plan use Anthracyclines chemotherapy next 1 month oncologist . 3 . All participant participate exercise training past 6 month 4 . All participant free acute chronic renal failure , Heart Failure , Myasthenia gravis , pregnancy history smoke . 1 . Participants exclude drop complete less 80 % training schedule .</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Walking Meditation</keyword>
	<keyword>Vascular Function</keyword>
	<keyword>Flow-mediated dilatation</keyword>
	<keyword>Breast Cancer Patients</keyword>
	<keyword>Anthracyclines Chemotherapy</keyword>
</DOC>